Resmed Inc (RMD) insider trading
Every open-market stock purchase and sale by Resmed Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Michael J. Farrell (CEO) and 2 others sold $5.4M in the last 90 days.
- Last company insider buy: Ronald R Taylor (Board member), $172K, 10 years ago.
- Congress: Alan Armstrong bought $1K to $15K, 7 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $22.4M (32 sales). Last close $229.94 on Oct 30, 2026.
Recent RMD insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 23, 2026 | Michael J Rider (General Counsel) | Sold | $102K |
| Oct 7, 2026 | Michael J. Farrell (CEO) | Sold | $1.1M |
| Oct 7, 2026 | Michael J. Farrell (CEO) | Bought (not open market) | — |
| Sep 8, 2026 | Michael J. Farrell (CEO) | Sold | $1.1M |
| Sep 8, 2026 | Michael J. Farrell (CEO) | Bought (not open market) | — |
| Sep 2, 2026 | Peter C Farrell (Director) | Sold | $228K |
| Aug 14, 2026 | Michael J. Farrell (CEO) | Bought (not open market) | — |
| Aug 14, 2026 | Aaron Bloomer (CFO) | Bought (not open market) | — |
| Aug 14, 2026 | Justin Leong (C-suite exec) | Bought (not open market) | — |
| Aug 14, 2026 | Michael J Rider (General Counsel) | Bought (not open market) | — |
| Aug 7, 2026 | Michael J. Farrell (CEO) | Sold | $1M |
| Aug 7, 2026 | Michael J. Farrell (CEO) | Bought (not open market) | — |
| Aug 5, 2026 | Peter C Farrell (Director) | Sold | $1.8M |
| Jul 7, 2026 | Michael J. Farrell (CEO) | Sold | $1.1M |
| Jul 7, 2026 | Michael J. Farrell (CEO) | Bought (not open market) | — |
| Jun 8, 2026 | Michael J. Farrell (CEO) | Sold | $968K |
| Jun 8, 2026 | Michael J. Farrell (CEO) | Bought (not open market) | — |
| Jun 1, 2026 | Michael J Rider (General Counsel) | Sold (not open market) | $51.2K |
| May 7, 2026 | Michael J. Farrell (CEO) | Sold | $1M |
| May 7, 2026 | Michael J. Farrell (CEO) | Bought (not open market) | — |
| Apr 7, 2026 | Michael J. Farrell (CEO) | Sold | $1.1M |
| Apr 7, 2026 | Michael J. Farrell (CEO) | Bought (not open market) | — |
| Apr 1, 2026 | Peter C Farrell (Director) | Sold | $450K |
| Apr 1, 2026 | Brett Sandercock (CFO) | Sold | $224K |
| Mar 27, 2026 | Alan Armstrong (Senator) | Bought | $1K–15K |
Who's trading RMD
- Michael J Rider, General Counsel: sold $139K (4 sales), last Oct 23, 2026
- Michael J. Farrell, CEO: sold $14.6M (12 sales), last Oct 7, 2026
- Peter C Farrell, Director: sold $5M (8 sales), last Sep 2, 2026
- Justin Leong, C-suite exec: other filings, last Aug 14, 2026
- Aaron Bloomer, CFO: other filings, last Aug 14, 2026
- Brett Sandercock, CFO: sold $2M (6 sales), last Apr 1, 2026
- Alan Armstrong, Senator: bought $8K (1 buy), last Mar 27, 2026
- Jan De Witte, Director: sold $646K (2 sales), last Nov 25, 2025
- Nicole Mowad-Nassar, Director: other filings, last Nov 24, 2025
- Harjit Gill, Director: other filings, last Nov 20, 2025
- Carol Burt, Director: other filings, last Nov 20, 2025
- Christopher DelOrefice, Director: other filings, last Nov 20, 2025
- Karen Drexler, Director: other filings, last Nov 20, 2025
- John Hernandez, Director: other filings, last Nov 20, 2025
- Ronald R Taylor, Director: other filings, last Nov 20, 2025
Get free alerts when an insider at Resmed Inc files a new trade →